Cited by 854Bone health and treatmentsAngiogenesis and VEGF in CancerBone Metabolism and Diseases

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Wood, Jeanette, Bonjean, Karine, Ruetz, Stephan, Bellahcène, Akeila, Devy, Laetitia, Foidart, Jean Michel, Castronovo, Vincent, Green, Jonathan R.·2002·The Journal of Pharmacology and Experimental Therapeutics

DOI 10.1124/jpet.102.035295

Open this paper in CoChat — free account

Abstract

Bisphosphonate drugs inhibit osteoclastic bone resorption and are widely used to treat skeletal complications in patients with tumor-induced osteolysis. We now show that zoledronic acid, a new generation bisphosphonate with a heterocyclic imidazole substituent, is also a potent inhibitor of angiogenesis. In vitro, zoledronic acid inhibits proliferation of human endothelial cells stimulated with fetal calf serum, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (IC(50) values 4.1, 4.2, and 6.9 microM, respectively), and modulates endothelial cell adhesion and migration. In cultured aortic rings and in the chicken egg chorioallantoic membrane assay, zoledronic acid reduces vessel sprouting. When administered systemically to mice, zoledronic acid potently inhibits the angiogenesis induced by subcutaneous implants impregnated with bFGF [ED(50), 3 microg/kg (7.5 nmol/kg) s.c.]. These findings indicate that zoledronic acid has marked antiangiogenic properties that could augment its efficacy in the treatment of malignant bone disease and extend its potential clinical use to other diseases with an angiogenic component.

Integrity signals

Registry

Crossref · 10.1124/jpet.102.035295

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,263
Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Bisphosphonates: Mechanisms of Action
Fleisch, H. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,109
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. R., & Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,039
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 844
Self-citation
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
Diel, I., Solomayer, E., Costa, S. D., Gollan, C., Goerner, R., Wallwiener, D. R., Kaufmann, M., & Bastert, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390601 · Cited by 809
In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices.
Montesano, R., Orci, L., & VASSALLI, P. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.5.1648 · Cited by 647
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Berenson, J. R., Lichtenstein, A. K., Porter, L., Dimopoulos, M. A., Bordoni, R. E., George, S., Lipton, A., Keller, A. M., Ballester, O., Kovacs, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 645

Flagged first, then by citations

Show all 33 references

1 of the 33 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Boissier, 2020, Zoledronic acid inhibits in vivo experimental angiogenesis (abstract B3)., Bone, 30, 38S
Bonjean, 2002, Zoledronic acid inhibits human endothelial cell adhesion to vitronectin and selectively alters the expression of extracellular matrix cell surface receptors (abstract B4)., Bone, 30, 38S

Sorted by citations

Items 601–700 of 845

Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome
Ferraro, M. C., O'Connell, N. E., Göebel, A., Hill, R. A., Curtis, F., Wilkinson, J., Gustin, S. M., Cashin, A. G., & McAuley, J. H. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-03693 · Cited by 4
Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer.
Spencer, S. D., Marini, B. L., & Figg, W. D. (2012) · PubMed · Cited by 4
Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach
Larid, G., Valayer, S., Jacquier, C., Lafforgue, P., Laredo, J. D., & Pham, T. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105589 · Cited by 4
Influence of antiresorptive/antiangiogenic therapy on the surgical treatment outcomes of experimentally induced peri-implantitis lesions
Ramanauskaitė, A., Krüger, N., Obreja, K., Borchert, F., Dahmer, I., & Schwarz, F. (2023) · Clinical Oral Investigations · doi:10.1007/s00784-023-05275-w · Cited by 4
Suppressive effect of vitamin K2 (menatetrenone) against bone mineral density loss after radiotherapy in uterine cancer patients
Kaneyasu, Y., Fujiwara, H., Akita, T., Tanaka, J., Shibata, Y., Nakagawa, T., Koh, I., Hirata, E., Hyodo, M., Miyamoto, T., et al. (2025) · Japanese Journal of Radiology · doi:10.1007/s11604-025-01733-5 · Cited by 4
Evaluation of the cytotoxic effect of chitosan-zoledronic acid nanoparticles and free zoledronic acid against a549 lung cancer cells using microfluidic technology
Khayati, M., Safari, H., Bagheri, F., & Kheiri, H. (2025) · Microfluidics and Nanofluidics · doi:10.1007/s10404-025-02794-8 · Cited by 4
Bisphosphonate induced osteonecrosis of the mandible
Subramaniam, R. M., & Miller, G. M. (2008) · European Journal of Radiology Extra · doi:10.1016/j.ejrex.2008.01.009 · Cited by 4
Prevention of bisphosphonates-induced osteonecrosis.
Baraldi, A., Fusco, V., Bellora, A., & Pini, M. (2007) · PubMed Central · Cited by 4
Enhancing the Oral Rehabilitation and Quality of Life of Bisphosphonate-Treated Patients: The Role of Dental Implants
Altalhi, A. M., Alsubaihi, A. A., Aldosary, M. M., Alotaibi, L. F., Aldosariy, N. M., Alwegaisi, A. K. S., Alghadeer, J. Y., & Aljowayed, A. H. (2023) · Cureus · doi:10.7759/cureus.46654 · Cited by 4
Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium
Vieillard, M.-H., Paccou, J., Cortet, B., Biver, E., Salleron, J., Falgayrac, G., & Penel, G. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1146-0 · Cited by 4
Osteonecrosis of the Jaw: Clinicopathologic and Radiologic Features
Sedghizadeh, P. P., & Jones, A. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-23639-1_12 · Cited by 4
[Research progress on bisphosphonate-related osteonecrosis of the jaws].
Jian, P., Qizhang, W., & Jiyuan, L. (2017) · PubMed Central · doi:10.7518/hxkq.2017.01.004 · Cited by 4
Implantes em pacientes com osteonecrose dos maxilares associado ao uso de bifosfonatos. Relato de caso e revisão de literatura
Coléte, J. Z., Hadad, H., Momesso, G. A. C., Filho, H. D. S., Fernandes, B. D. R., & Júnior, I. R. G. (2019) · ARCHIVES OF HEALTH INVESTIGATION · doi:10.21270/archi.v8i1.3129 · Cited by 4
Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines
Gökalp, C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05840-6 · Cited by 4
Maxillomalar Monoblock Removal, Reshaping, and Reinsertion in Paget’s Disease: 15-Year Follow-Up
Martinez-Lage, J. L., Almeida, F., Picón, M., Lorenzo, F., & Carrillo, R. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.013 · Cited by 4
[Bisphosphonates and bone metastases of solid tumors: therapeutic interest despite its anti-resorptive properties].
Clézardin, P. (2003) · PubMed · Cited by 4
Bisphosphonate-induced osteonecrosis of the jaw
Sivaramakrishnan, G., & Sridharan, K. (2014) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000007 · Cited by 4
RANK-Ligand inhibitor associated osteonecrosis of the jaw
Rashad, A., Smeets, R., & Heiland, M. (2013) · Europe PMC (PubMed Central) · doi:10.3205/iprs000037 · Cited by 4
A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients
Wang, Z., Lei, L., Cai, X., Chen, L.-Y., Yuan, M., Yang, G., Huang, P. C., & Xiaojia, W. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s103624 · Cited by 4
Osteonecrosis of the Jaw and Atypical Femoral Fractures
Shane, E. J., Khosla, S., & Burr, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00081-9 · Cited by 4
Oral Mucosal Ulceration Induced by Alendronic Acid: A Case Series
Finn, D. J., Field, A., Rajlawat, B. P., & Randall, C. (2018) · Dental Update · doi:10.12968/denu.2018.45.1.38 · Cited by 4
Conservative Approaches to Managing Medication-Related Osteonecrosis of the Jaw (MRONJ): A Narrative Review
Kamel, A. H. M., ALKINDI, F. A. S., Alharrasi, R., & AlKindi, N. (2025) · Odovtos - International Journal of Dental Sciences · doi:10.15517/6bm9sw81 · Cited by 3
Unraveling Jawbone Susceptibility: Distinctive Features Underlying Medication-Related Osteonecrosis
Paczona, B., Piffkò, J., & Janovszky, Á. (2026) · Dentistry Journal · doi:10.3390/dj14010018 · Cited by 3
Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone‐Stabilizing Drugs
Saur, F., Keinki, C., Cramer, A., Büntzel, J., & Hübner, J. (2024) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70024 · Cited by 3
Clinical investigation of bisphosphonate-related osteonecrosis of the jaws in patients with malignant tumors
Kim, S.-K., & Kwon, T. (2012) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2012.38.3.152 · Cited by 3
Hypercalcémie de l'adulte
Vieillard, M.-H., Gerot-Legroux, I., & Cortet, B. (2009) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(09)44926-x · Cited by 3
Effects of ranibizumab and zoledronic acid on endometriosis in a rat model
Özdemir, E. Ü., Adalı, E., Taşkın, M. İ., Yavaşoğlu, A., Aktuğ, H., Oltulu, F., & Inceboz, U. S. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06393-0 · Cited by 3
Effect of local administration of bisphosphonate on orthodontic anchorage – A systematic review of animal studies
Harikrishnan, S., & Ramasamy, N. (2022) · Journal of Orthodontic Science · doi:10.4103/jos.jos_189_21 · Cited by 3
Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?
Ülker, G. M. Y., Günbatan, M., Duygu, G., Tekkeşin, M. S., & Tomruk, C. Ö. (2023) · Biomedicines · doi:10.3390/biomedicines11030758 · Cited by 3
Alterations in macrophage polarization in the craniofacial and extracranial skeleton after zoledronate application and surgical interventions – an in vivo experiment
Struckmeier, A., Wehrhan, F., Preidl, R. H. M., Mike, M., Mönch, T., Eilers, L., Ries, J., Trumet, L., Lutz, R., Geppert, C. I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204188 · Cited by 3
Alendronate reduces periosteal microperfusion in vivo
Kundert, D. N., Tavassol, F., Kampmann, A., Gellrich, N., Lindhorst, D., Precht, M. M., & Schumann, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19468 · Cited by 3
Bisphosphonates with high bone-resorption-capacity promote osteonecrosis of the jaw development after tooth extraction in mice
Kubo, R., Tajiri, R., Yamada, H., Nakayama, H., & Miyamoto, T. (2025) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-025-01608-9 · Cited by 3
A fogpótláskészítés szempontjai biszfoszfonáttal kezelt idős páciens esetén
Bata, Z., Szabó, E. V., & Tóth, Z. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31200 · Cited by 3
Bone-Specific Drugs and Osteonecrosis of Sites Other Than the Jaw: A Nationwide Cohort Study
Nordström, P., Bergman, J., Ballin, M., Björk, S., & Nordström, A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4040 · Cited by 3
Targeting mevalonate pathway by zoledronate ameliorated pulmonary fibrosis in a rat model: Promising therapy against post‐COVID‐19 pulmonary fibrosis
Mohamed, R. H., hay, N. H. A., Fawzy, N. M., Tamim, Y. M., Karem, M., Yehia, D. A. Y., Abdel-Maksoud, O. M., & Abdelrahim, D. S. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12994 · Cited by 3
The Role of Bisphosphonates in Bone Metastasis
MacKenzie, M. J., & Major, P. P. (2004) · Cancer metastasis · doi:10.1007/978-1-4020-2036-0_13 · Cited by 3
Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
Freedman, O. C., Amir, E., & Clemons, M. J. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.03.001 · Cited by 3
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro
Carbonare, L. D., Valenti, M. T., Bertoldo, F., Fracalossi, A., Balducci, E., Azzarello, G., Vinante, O., & Cascio, V. L. (2007) · Aging Clinical and Experimental Research · doi:10.1007/bf03324673 · Cited by 3
Intérêt de la scintigraphie au technétium 99 métastable (99mTc) pour la prise en charge des ostéonécroses liées aux bisphosphonates
Agossa, K., Santucci, J. J., Querellou, S., & Boisramé, S. (2011) · Médecine Buccale Chirurgie Buccale · doi:10.1051/mbcb/2011115 · Cited by 3
Successful surgical treatment of a case of bisphosphonate-related osteonecrosis of the mandible
Asaka, Y., Makita, H., Yonemoto, K., Yamashita, T., Kato, K., & Shibata, T. (2009) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.55.354 · Cited by 3
Bisphosphonate-related osteonecrosis of the jaws: a call for multidisciplinary approaches.
Parisuthiman, D. (2007) · PubMed · Cited by 3
Polyostotic Melorheostosis: Approach to Clinical Evaluation and Management
Teoh, C. C., Teoh, S. R. Z., Chieng, D. C. H., Ang, X. Y., & Hassim, M. H. M. (2019) · Open Journal of Orthopedics · doi:10.4236/ojo.2019.97014 · Cited by 3
Vascular Endothelial Growth Factor and Osteogenic-Angiogenic Coupling
Towler, D. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00066-5 · Cited by 3
Optimisation des traitements orthodontiques chez les patients sous biphosphonates
Zahrowski, J. J. (2011) · L Orthodontie Française · doi:10.1051/orthodfr/20010032 · Cited by 3
The influence of local and systemic factors upon dental implant osseointegration
Naghshbandi, J. (2020) · Saudi Journal of Oral Sciences · doi:10.4103/sjos.sjoralsci_79_19 · Cited by 3
Angiogenesis in Breast Cancer
Brooks, M. N., & Folkman, M. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5221-0.00032-2 · Cited by 3
Investigation of the Antiangiogenic Properties of Zoledronic Acid by Using Chorioallantoic Membrane Model
Gülcü, A., & Akkaya, Ö. (2022) · Dose-Response · doi:10.1177/15593258221093410 · Cited by 3
Preclinical Profile of Zoledronic Acid in Prostate Cancer Models
Green, J. R. (2004) · European Urology Supplements · doi:10.1016/j.eursup.2004.08.008 · Cited by 3
Self-citation
Bisphosphonates and oral cavity avascular bone necrosis: A review of 12 cases
Salesi, N., Pistilli, R., Marcelli, V., Govoni, F. A., Cocco, B. D., Pacetti, U., Fonso, C. D., Ciorra, A., Natali, M., & Veltri, E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.18628 · Cited by 3
Melorheostosis: Clinical, radiological, and histopathological features with a literature review
Koca, E., Kavak, Ş., Demir, B., Çomunoğlu, N., Kantarcı, F., & Koca, O. (2025) · Physiological Reports · doi:10.14814/phy2.70652 · Cited by 2
Osteoblastic cell responses to zoledronate treatment in-vitro: A systematic review
Florez-Martin, M., Radu, A.-M., Shakib, K., & Jell, G. (2026) · Bone · doi:10.1016/j.bone.2026.117796 · Cited by 2
Ostéoradionécrose et ostéonécrose des maxillaires aux bisphosphonates
Salino, S., Bodard, A., & Timour, Q. (2010) · Cited by 2
Melorheostosis: Case report of rare disease
Mehrotra, D. R., Kumar, P., Chaudhary, D., Patel, P., & Singh, A. K. (2018) · International Journal of Orthopaedics Sciences · doi:10.22271/ortho.2018.v4.i1g.66 · Cited by 2
Hypoxia and angiogenesis: from primary tumor to bone metastasis
Reeves, K. J., & Brown, N. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00016-9 · Cited by 2
Ostéonécroses des maxillaires sous bisphosphonates
Maes, J., Vieillard, M.-H., Penel, G., Raoul, G., & Ferri, J. (2007) · Cited by 2
The Impact of Women’s Oral Health on Systemic Health
Haskin, C., & Mobley, C. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00100-x · Cited by 2
Bisphosphonates et ostéonécrose maxillomandibulaire
Saussez, S., Filleul, O., & Loeb, I. (2008) · Revue de Stomatologie et de Chirurgie Maxillo-faciale · doi:10.1016/j.stomax.2008.09.008 · Cited by 2
Jaw bone necrosis and bisphosphonates: Microanatomical questions
BOYDE, A. (2006) · BoneKEy-Osteovision · doi:10.1138/20060229 · Cited by 2
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates
Sanna, G., Preda, L., Bruschini, R., Rocca, M. C., Verri, E., Bellomi, M., Goldhirsch, A., & Nolè, F. (2008) · Acta Oncologica · doi:10.1080/02841860701592418 · Cited by 2
Bisphosphonates and BMU birth rate: response to comments by Ott
Seeman, E. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1027-6 · Cited by 2
Bone quality and osteonecrosis of the jaw induced by bisphosphonates
Hemar, J., Sauvigné, T., Bodard, A., & Boivin, G. (2011) · Médecine Buccale Chirurgie Buccale · doi:10.1051/mbcb/2011144 · Cited by 2
Cellulitis Extending from Submandibular to Temporal Region Originating from Bisphosphonate-related Osteonecrosis of the Mandible
Ariyoshi, Y., Ueno, T., Ito, Y., & Kimura, Y. (2013) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.22.141 · Cited by 2
Osteonecrosis of the myeloma patients treated with bisphosphonates.
Capalbo, S. F., Franzese, M. G., & Palumbo, G. (2007) · PubMed Central · Cited by 2
Biological Therapies for Metastatic Breast Cancer: Antiangiogenesis
Harris, A. L., & Generali, D. (2007) · Springer eBooks · doi:10.1007/978-3-540-28266-2_33 · Cited by 2
Frequent low-dose bisphosphonate therapy
Clézardin, P. (2007) · Bone · doi:10.1016/j.bone.2007.06.030 · Cited by 2
Humanizing a Mouse Gene for Human Therapeutics: Lessons From Denosumab
Little, D. G. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081221 · Cited by 2
Bisphosphonates, oral implants and osteonecrosis of the jaw: a review and guidelines
Warreth, A., & Denise (2010) · Cited by 2
Two cases of bisphosphonate-associated osteonecrosis of the mandible
Tanaka, N., Kishimoto, H., Takaoka, K., Hashitani, S., Sakurai, K., & Urade, M. (2007) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.53.392 · Cited by 2
Bisphosphonate-related osteonecrosis of the jaw: review from pathological observation
Ikeda, T., & Yamaguchi, A. (2010) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.56.352 · Cited by 2
Blindness Resulting from Bisphosphonate Related Osteonecrosis of the Skull Base
Faraji, F., & Brunworth, J. (2016) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0036-1579971 · Cited by 2
Special Committee on Medication-Related Osteonecrosis of the Jaws:
Ruggiero, S. L., Dodson, T. B., Goodday, R. H. B., Aghaloo, T. L., & Mehrotra, B. (2014) · Cited by 2
Risedronate Has No Adverse Effects on Mouse Haematopoiesis
Šefc, L., Broulik, P. D., Pelichovská, T., & Nečas, E. (2007) · Folia Biologica · doi:10.14712/fb2007053040143 · Cited by 2
Osteoporosis in premenopausal women
Payer, J., Smaha, J., Kužma, M., Killinger, Z., & Jackuliak, P. (2021) · Vnitřní lékařství · doi:10.36290/vnl.2021.075 · Cited by 2
Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy
Stephan, C., Ralla, B., Bonn, F., Diesner, M., Lein, M., & Jung, K. (2022) · Cancers · doi:10.3390/cancers14061560 · Cited by 2
Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type
Sakamoto, Y., Sawada, S., & Kojima, Y. (2024) · Cureus · doi:10.7759/cureus.60223 · Cited by 2
Bisphosphonates and jaw osteonecrosis
Maahs, M. A. P., Nora, V. P., Azambuja, A. A., & Cherubini, K. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3
Quesada‐Gómez, J. M., Santiago‐Mora, R., Navarro-Valverde, C., Dorado, G., & Casado‐Díaz, A. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.018 · Cited by 2
Does Medication-related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?
Asan, C. Y., Gönen, Z. B., Akkoyun, E. F., Kılıç, E., & Alkan, A. (2020) · Meandros Medical And Dental Journal · doi:10.4274/meandros.galenos.2018.44366 · Cited by 2
Bone Metastases
Coleman, R. E., & Holen, I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50061-0 · Cited by 2
Zoledronic Acid and Angiogenesis
Santini, D., Vincenzi, B., & Tonini, G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4408 · Cited by 2
Osteonecrosis of the jaw after treatment with bisphosphonates is irreversible, so the focus must be on prevention
Landis, B. N., Richter, M., Dojcinovic, I., & Hugentobler, M. (2007) · Primary Dental Care · doi:10.1308/135576107779398084 · Cited by 2
Bisfosfonatos e osteonecrose dos maxilares
Felgueiras, J. C. (2008) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
How Surgery Affects Patients with Jaw Osteonecrosis? A Quality of Life Analysis Study
Biçer, A., İBRAHİMLİ, N., Canbolat, O. C., & Gürler, T. (2022) · Turkish Journal of Osteoporosis · doi:10.4274/tod.galenos.2021.33340 · Cited by 1
Bifosfonatlar ve Çenelerde Görülen Osteonekroz
Tanrikol, B., & Mağat, G. (2022) · Sağlık Bilimlerinde Değer · doi:10.33631/sabd.1115442 · Cited by 1
Diş Hekimliği Öğrencilerinin İlaca Bağlı Olarak Çene Kemiklerinde Görülen Osteonekroz (MRONJ) ile İlgili Bilgi Düzeylerinin Değerlendirilmesi
Şahin, M., Doğan, F. B., & Demir, A. (2024) · Selcuk Dental Journal · doi:10.15311/selcukdentj.1334465 · Cited by 1
Characterization and therapeutic effects of an atorvastatin graphene oxide hydrogel on medication induced osteonecrosis of the jaws in female rats
Silva, G. D. A., de Sousa, V. C., Freires, A. E. D. J., Costa, A. G. R., Mattos, A. L. A., Costa, S., Bernardino, M. J. C., Pereira, K. M. A., Ricardo, N. M. P. S., Bezerra, M. M., et al. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103467 · Cited by 1
Angiogenesis in Multiple Myeloma: 25 Years of Research in This Field
Ribatti, D. (2025) · European Journal Of Haematology · doi:10.1111/ejh.70023 · Cited by 1
The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells
Bria, J., Chiarella, E., Sovereto, J., Baudi, F., Greco, M., FOTI, D. P., Giudice, A., & Vito, A. D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335744 · Cited by 1
Polypharmacy and Its Impact on Oral Health
Kulkarni, S., & Yeoh, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-05888-1_23 · Cited by 1
Unraveling stress fractures: from cellular and molecular mechanisms to therapeutic approaches
Pu, P., Zhang, X., Zhang, S., Chen, H., Lei, Q., Song, T., Wang, C., Xie, Y., & Chen, L. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101185 · Cited by 1
Direct and indirect antitumor activity of zoledronic acid
Massaia, M., Mariani, S., Pantaleoni, F., Muraro, M., Peola, S., Hwang, S. Y., Castella, B., & Matta, G. (2009) · Hematology Meeting Reports · doi:10.4081/hmr.v1i8.294 · Cited by 1
Can osteoclasts be excluded? (Reply)
Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., et al. (2007) · Nature · doi:10.1038/nature05658 · Cited by 1
Martwica kości szczęk po długotrwałym stosowaniu bisfosfonianów
Litwiniuk, M. M., & Staszkiewicz, A. (2008) · Via Medica Journals · Cited by 1
Prolonged Antiresorptive Treatment of Lytic Prostate Cancer Xenografts in Mouse Bone Results in Tumor Necrosis
Blair, J., Modzelewski, J. R. K., Perryman, L., Russell, P. J., Seibel, M. J., & Dunstan, C. R. (2009) · doi:10.29685/jcm.200902.0003 · Cited by 1
Bisphosphonate-Related Osteonecrosis of the Mandible Secondary to Postural Pressure
Yankova, Z., Ganesan, K., SHAH, K. A., & Russell, J. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.06.230 · Cited by 1
Clinician's corner: a clinico-pathologic correlation.
Ashrafi, A., & Oreadi, D. (2014) · PubMed · Cited by 1
Bisphosphonate-Related Osteonecrosis of the Jaws: a real Challenge for Dentists
Albu, A. I., Petrovan, C., Mariana, P., Albu, D., Csinszka, K.-I. A., Golu, M. V., & Copotoiu, C. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0034 · Cited by 1
Osteonecrosis of the jaw with sunitinib and zoledronic acid combination: A case report
Tolunay, P. K., Yaşar, A., Utkan, G., & Ürün, Y. (2018) · Journal of Oncological Sciences · doi:10.1016/j.jons.2018.04.004 · Cited by 1
Diabetes mellitus and its association with infection and osteonecrosis of the jaw
Ruggiero, B. L., & Edwards, S. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820605-8.00008-5 · Cited by 1
Selective Binding of pVTK Peptide- and Bisphosphonate-Functionalized Micelles to Prostate Cancer Cells, Osteoblasts, and Osteoclasts
Aydin, Ö. F., Tiruchinapally, G., Youssef, I., Ramaraju, H., Durmaz, Y. Y., Kozloff, K. M., Kohn, D. H., & ElSayed, M. E. H. (2022) · Precision Nanomedicine · doi:10.33218/001c.33142 · Cited by 1

Authors: Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R.
Affiliations: Novartis (Switzerland) (CH)
University of Liège (BE)
ORCID: Bellahcène, Akeila
Venue: The Journal of Pharmacology and Experimental Therapeutics
Publisher: Elsevier BV
Published: 2002-01
Volume: 302
Issue: 3
Pages: 1055-1061
ISSN: 0022-3565 (ISSN-L)
DOI: 10.1124/jpet.102.035295
OpenAlex: W2144860907
Cited by: 854
References: 33
Citations by year: 2026: 13 · 2025: 17 · 2024: 14 · 2023: 20 · 2022: 17 · 2021: 18 · 2020: 22 · 2019: 34 · 2018: 23 · 2017: 20 · 2016: 24 · 2015: 38 · 2014: 46 · 2013: 44 · 2012: 36
FWCI: 14.78
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
PubMed (publishedVersion)
Open Repository and Bibliography (University of Liège) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Bone health and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords: zoledronic acid, bisphosphonates, antiangiogenic activity, angiogenesis inhibition, endothelial cell proliferation, basic fibroblast growth factor, vascular endothelial growth factor, endothelial cell adhesion, endothelial cell migration, tumor-induced osteolysis, malignant bone disease, chorioallantoic membrane assay
MeSH terms: Zoledronic Acid, Pamidronate, Cell Adhesion, Cell Cycle, Cell Movement, Cells, Cultured, Chemotaxis, Chorion, Diphosphonates, Endothelium, Vascular, Growth Substances, Humans, Imidazoles, Lymphokines, Muscle, Smooth, Vascular, Fibroblast Growth Factor 2, Endothelial Growth Factors, Apoptosis, Image Cytometry, Angiogenesis Inhibitors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks